EN DE

Colgate-Palmolive (India) Limited (COLPAL) Fair Value & Analysis

Consumer Defensive · IN · Market cap ₹547B

CP Colgate-Palmolive (India) Limited COLPAL · NSE
Price₹1,981
Fair Value₹945.90
Upside-52.3%
Quality80/100
Watch Colgate-Palmolive (India) Limited for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Highly profitable · 22.0% net margin
Low debt · generates free cash flow
2.39% dividend yield
Mixed vs. peers (8/14)
Wide moat 92/100
Evidence: High Range ₹695.01 – ₹1,169 Share as image

Fair value as of: Aug 13, 2026

From 26 valuation models · updated yesterday

Share price −1.5% over the past month.

A strong business, but screening 52% overvalued on our models.

What matters now

  • A high-quality business (quality 80/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
  • The price sits above even our optimistic bull case (₹1,169). The favourable scenario is already priced in.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

₹3,683 ₹1,259 Fair Value ₹945.90 Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range ₹1,259 – ₹3,683 · fair‑value band ₹695.01 – ₹1,169 · the ₹1,981 price screens above the ₹945.90 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Colgate-Palmolive (India) Limited (COLPAL) currently trades at ₹1,981, while our model-based Fair Value estimate is ₹945.90, implying the stock looks roughly 52.3% overvalued today. The Quality Score stands at 80/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Colgate-Palmolive (India) Limited generated revenue of ₹60.4B at a net margin of 22.0%. Revenue grew 9.1% year over year. It earns a return on equity of 81.6%. The balance sheet holds a net cash position of ₹14.2B. Fundamentals as of Aug 13, 2026

Our scenario range runs from ₹695.01 (bear case) to ₹1,169 (bull case); at ₹1,981, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 19% below its 52-week high and 12% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -38% fair-value upside, at -52%, COLPAL screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF ₹861.03 ₹1,286 ₹1,929 80
Residual Income ₹214.17 ₹257.09 ₹1,396 76
Rev-Margin DCF ₹466.34 ₹638.94 ₹842.34 74
All 26 models by family
DCF Models
FCF DCF ₹845.08 ₹1,323 ₹2,093 38
Owner Earnings ₹671.15 ₹1,044 ₹1,645 31
5Y Revenue Exit ₹466.34 ₹629.07 ₹826.42 39
5Y EBITDA Exit ₹716.61 ₹1,099 ₹1,542 41
5Y P/E Exit ₹774.47 ₹1,208 ₹1,662 38
10Y Revenue Exit ₹583.39 ₹765.80 ₹994.64 36
10Y EBITDA Exit ₹754.31 ₹1,100 ₹1,556 37
10Y P/E Exit ₹792.09 ₹1,178 ₹1,650 35
Earnings-Based
Graham-Dodd ₹331.35 ₹1,050 ₹1,399 54
Lynch FV ₹230.92 ₹329.88 ₹428.85 50
PEG = 1.0 ₹230.92 ₹329.88 ₹428.85 46
EPV ₹519.08 ₹601.16 ₹674.11 59
Dividend Discount
Gordon GGM ₹490.57 ₹1,071 ₹1,802 70
DDM Multi-Stage ₹490.57 ₹833.90 ₹1,116 61
Multiples
P/E Multiple ₹767.45 ₹1,023 ₹1,279 63
P/S Multiple ₹266.27 ₹355.02 ₹443.78 58
P/B Multiple ₹240.25 ₹320.33 ₹400.42 55
EV/EBIT ₹861.98 ₹1,131 ₹1,401 53
EV/EBITDA ₹724.23 ₹947.64 ₹1,171 54
EV/Revenue ₹286.99 ₹386.84 ₹486.69 43
Asset-Based
NCAV (Graham) ₹29.12 ₹39.02 ₹58.24 50
Growth DCF
Growth DCF ₹861.03 ₹1,286 ₹1,929 80
Rev-Margin DCF ₹466.34 ₹638.94 ₹842.34 74
Economic Profit
Residual Income ₹214.17 ₹257.09 ₹1,396 76
ROIC Compounder ₹520.41 ₹604.24 ₹679.81 72
Growth Earnings
Growth-Adj P/E ₹638.57 ₹912.24 ₹1,186 68

Widest divergence: DCF Models (₹1,099) versus Asset-Based (₹39.02). Highest evidence: Growth DCF (80).

Notify me when COLPAL reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) ₹60.4B
Revenue growth (YoY) +9.1%
Net margin 22.0%
Return on equity 81.6%
Free cash flow ₹17.9B FY2026
P/E ratio 40.6
More key figures
Operating margin 29.8%
EPS (TTM) ₹48.79
Dividend yield 2.4%
EPS growth (YoY) -0.5%
Net cash ₹14.2B FY2026

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 80/100

Of which business quality 80 · Market factors (momentum, volatility) 48

Profitability 98
Margins and returns on capital today
Quality Growth 8
Are margins and returns improving?
Cashflow 90
Earnings quality: real cash, not paper profit
Fin. Strength 93
Balance sheet, leverage, solvency risk
Investment 90
Disciplined investing over empire-building
Low Volatility 89
Calm price path (market factor)
Momentum 32
Price trend over the last 3–12 months (market factor)
52W Momentum 29
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Colgate-Palmolive (India) Limited manufactures and trades in personal and oral care products in India. The company offers toothpastes, toothpowder, toothbrushes, mouth wash, rinses, hand washes, and shower gels under the Colgate brand name. It also offers soaps, cosmetics, and toilet preparations. In addition, the company exports its products.

Full company description

Colgate-Palmolive (India) Limited manufactures and trades in personal and oral care products in India. The company offers toothpastes, toothpowder, toothbrushes, mouth wash, rinses, hand washes, and shower gels under the Colgate brand name. It also offers soaps, cosmetics, and toilet preparations. In addition, the company exports its products. The company was incorporated in 1937 and is headquartered in Mumbai, India.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Colgate-Palmolive (India) Limited reported revenue of ₹60.4B in FY2026 versus ₹50.7B in FY2022, a compound +4.5%/yr. Reported net income was ₹13.3B in FY2026, compounding +5.3%/yr from FY2022.

Growth Quality 78/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2026)
₹60.4B
Latest YoY
+0.6%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.2%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.5%
Avg. growth/yr (28Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+6.7%
Revenue +4.5%/yr
FY22 ₹50.7B
FY23 ₹51.9B
FY24 ₹56.4B
FY25 ₹60.0B
FY26 ₹60.4B
Net income +5.3%/yr
FY22 ₹10.8B
FY23 ₹10.5B
FY24 ₹13.2B
FY25 ₹14.4B
FY26 ₹13.3B
Character of growth · EPS growth decomposed (2015-2026) +10.1 % p.a.
Revenue per share +4.6 pp

of which total revenue +4.6 pp · buybacks/dilution +0.0 pp

EBIT margin +4.3 pp
Tax rate +0.7 pp
Residual (interest, one-offs) +0.5 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

COLPAL screens 52% overvalued. Compare with The Procter & Gamble Company →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Colgate-Palmolive (India) Limited Fair Value". https://www.fairvalue-calculator.com/stock/COLPAL

Peer Group

Household & Personal Products · 251 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 80 · Top 25%
Fair Value upside −52% · Bottom 25%
Return on equity (TTM) 82% · Top 25%
Return on assets 34% · Top 25%
Net margin (TTM) 22% · Top 25%
Operating margin (TTM) 30% · Top 25%
Revenue growth 9% · Top 25%
Dividend yield (TTM) 2.4% · Below median

Valuation Multiples vs Household & Personal Products median · lower = cheaper

P/E (TTM) 40.6× · Pricier than 75% of peers
P/B 34.54× · Pricier than 75% of peers
P/S (TTM) 9.07× · Pricier than 75% of peers
P/FCF 0.3× · Cheaper than median
EV/EBITDA 28.7× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 28
FUTURE 46 · sector 4
PAST 100 · sector 27
HEALTH 100 · sector 98
DIVIDEND 48 · sector 50

VALUE 0: the price sits above our fair-value range.

Insider activity: 28/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
The Procter & Gamble Company PG $146.80 $108.16 -26%
Unilever PLC ULN 1,080 MXN 973.58 MXN -10%
Hindustan Unilever Limited HINDUNILVR ₹2,063 ₹789.46 -62%
Essity AB ESSITYA kr 276.50 kr 250.02 -10%
Godrej Consumer Products Limited GODREJCP ₹936.90 ₹367.64 -61%
Marico Limited MARICO ₹855.00 ₹233.05 -73%
APR Co 278470 397,000 KRW 137,521 KRW -65%
Dabur India Limited DABUR ₹411.25 ₹175.59 -57%
PT Unilever Indonesia Tbk UNVR 1,760 IDR 1,928 IDR +10%
Amorepacific Corporation 090430 135,700 KRW 84,785 KRW -38%

Compare Colgate-Palmolive (India) Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Colgate-Palmolive (India) Limited (COLPAL) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of ₹945.90 versus a price of ₹1,981, about −52% (overvalued).
What is the fair value of COLPAL?
Our model-based fair value for Colgate-Palmolive (India) Limited is ₹945.90 (as of Aug 13, 2026), built from audited fundamentals. The current price is ₹1,981.
What is the quality score of COLPAL?
Colgate-Palmolive (India) Limited has a Quality Score of 80/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Colgate-Palmolive (India) Limited (COLPAL)?
Colgate-Palmolive (India) Limited reported trailing-twelve-month revenue of about ₹60.4B (latest available figure, as of Aug 13, 2026).
What is the net profit margin of COLPAL?
The net profit margin of Colgate-Palmolive (India) Limited is about 22.0%, meaning it keeps roughly 22.0% of revenue as net income. Based on the latest reported figures.
Does Colgate-Palmolive (India) Limited pay a dividend?
Colgate-Palmolive (India) Limited currently shows a dividend yield of about 2.39% relative to its recent price (as of Aug 13, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Colgate-Palmolive (India) Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.